Recent studies also showed that FABP4 is one of the novel adipocyte-derived bioactive molecules referred to as adipokines [13] and that elevated circulating FABP4 level is associated with obesity, insulin resistance, hypertension, cardiac dysfunction and atherosclerosis [14]–[20]. This evidence concerns the gene FABP4 and atherosclerosis.